Hydroxyurea and Anagrelide Combination Therapy in Patients with Chronic Myeloproliferative Diseases Resistant or Intolerant to Monotherapy

Publisher： Karger

E-ISSN： 1421-9662|120|4|195-198

ISSN： 0001-5792

Source： Acta Haematologica, Vol.120, Iss.4, 2009-01, pp. : 195-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Angiogenesis in Chronic Myeloproliferative Diseases

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 177-183

Karger

Access to resources Recommend Favorite

Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine Resistance

By  

Intervirology, Vol. 57, Iss. 1, 2013-08 ,pp. : 8-16

Karger

Access to resources Recommend Favorite

Long‐term patient‐reported outcomes from an open‐label safety and efficacy study of bosutinib in Philadelphia chromosome–positive chronic myeloid leukemia patients resistant or intolerant to prior therapy

By  

CANCER, Vol. 124, Iss. 3, 2018-02 ,pp. : 587-595

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adefovir and Lamivudine Combination Therapy in Patients with Entecavir-Resistant Chronic Hepatitis B: Antiviral Responses and Evolution of Mutations

By  

Intervirology, Vol. 57, Iss. 5, 2014-06 ,pp. : 239-247

Karger

Access to resources Recommend Favorite

The Feasibility of Discontinuing Lamivudine in Lamivudine-Resistant Chronic Hepatitis B Patients on Lamivudine and Adefovir Combination Therapy

By  

Intervirology, Vol. 57, Iss. 6, 2014-09 ,pp. : 337-343

Karger

Access to resources Recommend Favorite